Portola Pharmaceuticals Overview

Portola Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PTLA.

Quarterly EBIT

-$58.44M

↑ 18.47% YoY

As of Mar 31, 2020

Annual EBIT (TTM)

-$246.14M

↑ 23.46% YoY

Trailing 12 months ending Mar 31, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin